ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

HCM Hutchmed (china) Limited

352.00
14.00 (4.14%)
10 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Hutchmed (china) Limited LSE:HCM London Ordinary Share KYG4672N1198 ORD USD0.10
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  14.00 4.14% 352.00 350.00 351.00 353.00 342.00 348.00 243,766 16:35:27
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 838M 100.78M - N/A 0
Hutchmed (china) Limited is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker HCM. The last closing price for Hutchmed (china) was 338p. Over the last year, Hutchmed (china) shares have traded in a share price range of 173.60p to 353.00p.

Hutchmed (china) currently has 871,256,270 shares in issue.

Hutchmed (china) Share Discussion Threads

Showing 2026 to 2050 of 4125 messages
Chat Pages: Latest  93  92  91  90  89  88  87  86  85  84  83  82  Older
DateSubjectAuthorDiscuss
05/6/2019
08:52
Back to the same old 10% spread too!
nhb001
04/6/2019
16:31
Major pipeline news may help, until then we are drifting
nerdofsteel
04/6/2019
12:28
It was combo therapy re Retrovir that provided effective relief for AIDs patients.Far from new,very much in the limelight.
steeplejack
03/6/2019
08:39
I'm not sure they will help liquidity unless the spread narrows. Look at BUR and FEVR for comparably sized AIM companies where spread is almost always less than 0.5%, compared to near 5% here. ADRs will be more attractive until that is sorted imo
mad foetus
03/6/2019
08:18
From today's South China Morning Post, here is a great article on HK Biotech IPO's, and some interesting performance statistics since IPO. Nice mention of Brad Loncar's China Biopharma Index too.
nerdofsteel
02/6/2019
17:10
there seems to be a lot of discussion and social media traffic generated by the concept of drug combination therapy at this years ASCO, not a new concept but there certainly appears to be a lot of excitement about how combinations can help patients
nerdofsteel
02/6/2019
16:44
Our company has been nominated for awards in the following 2 categories at this years European Mediscience Awards:-



1. Breakthrough of the Year
2. Chief Executive of the Year

nerdofsteel
02/6/2019
13:13
Here is a great discussion on NSCLC and immunotherapies from this years ASCO - one of the panelists is Tony Mok, a Non-Exec Director at Chi-Med whom I have had the pleasure of meeting at the AGM
nerdofsteel
02/6/2019
09:06
apologies Lauders, I do read your posts but missed #1945 or have a very bad memory! Please do keep posting! ;o-)

ASCO2019 post session this afternoon, I suspect we will see some comments by the Oncology community later in the day

nerdofsteel
01/6/2019
16:50
Last two posts repeat what I posted in post #1945. Guess nobody reads LOL!

Never mind, think we all agree on HCM being higher in the future.

lauders
01/6/2019
08:25
Nerdofsteel
1 Jun '19 - 08:24 - 1949 of 1949
0 0 0
Trinity Delta issued an updated research note on Thursday



I continue to Buy


$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$


Hutchison China MediTech

Timing is right for a Hong Kong debut

Update | 30 May 2019

Share this note
AddThis Sharing Buttons
Share to Twitter
TwitterShare to LinkedIn
LinkedIn

Approval of EGM resolutions paves the way for the IPO of Hutchison China MediTech (Chi-Med) on the Hong Kong Stock Exchange (SEHK) in the coming months. This IPO should enhance Chi-Med’s access to capital, broaden its shareholder base, further raise its profile in its home market, and, importantly, improve liquidity. Liquidity will be further boosted by an associated global offering (size and structure are not yet disclosed), the secondary placement of shares by majority shareholder CK Hutchison Holdings Ltd, and a share split effective May 30th. Each ordinary AIM share is being divided into 10 new shares; an adjustment to the ADS ratio ensures there is no effect on the NASDAQ trading price. Accounting for this share split, our valuation remains $35.57/ADS ($4.74bn) but is now £5.47/share (£3.65bn) vs £54.72/share previously.

waldron
01/6/2019
08:24
Trinity Delta issued an updated research note on Thursday

hxxps://www.trinitydelta.org/research-notes/timing-is-right-for-a-hong-kong-debut/

I continue to Buy

nerdofsteel
01/6/2019
08:24
Agreed, I have been buying ADR's, also a bit of a currency play too
nerdofsteel
31/5/2019
09:10
SJ
Buy adrs. More liquidity less spread.

dbadvn
31/5/2019
08:27
10% nominal spread on the new share quote.Quite ridiculous.
steeplejack
30/5/2019
14:28
See Trinity Delta released this today:

Approval of EGM resolutions paves the way for the IPO of Hutchison China MediTech (Chi-Med) on the Hong Kong Stock Exchange (SEHK) in the coming months. This IPO should enhance Chi-Med’s access to capital, broaden its shareholder base, further raise its profile in its home market, and, importantly, improve liquidity. Liquidity will be further boosted by an associated global offering (size and structure are not yet disclosed), the secondary placement of shares by majority shareholder CK Hutchison Holdings Ltd, and a share split effective May 30th. Each ordinary AIM share is being divided into 10 new shares; an adjustment to the ADS ratio ensures there is no effect on the NASDAQ trading price. Accounting for this share split, our valuation remains $35.57/ADS ($4.74bn) but is now £5.47/share (£3.65bn) vs £54.72/share previously.

lauders
30/5/2019
11:12
Anyone looking at the chart today and not following the story will be in for a shock! Hope everyone is on the ball ;-) I will only be able to check what Selftrade did re: my account later when I finish work. Hope all is OK. They already contacted me twice to say that a split was going to take place.
lauders
30/5/2019
11:08
I am suffering from the usual dreadful AJ Bell platform, nothing updated and I cannot trade in HCM either. I will continue to buy ADR's.
nerdofsteel
30/5/2019
10:21
Hamsterdam - You're lucky I use iiand mine aren't even showing
horburyjunction
30/5/2019
09:36
Iweb updated both share price and quantity simultaneously. Should be the norm surely
shaker44
30/5/2019
09:24
Might be a day or two before Barclays updates in my experience.
steeplejack
30/5/2019
09:15
I have Barclays stockbrokers account-
1.yet to update number of shares.
2. Shows new share price. Hence, My portfolio valuation is showing ‘72% decline’!
3.One Good thing-buy price £4.75 an improvement of £2 compared to last night’s closing price £45.50.

sportii
30/5/2019
08:32
My Interactive Investor account has now been updated. I now own 6910 shares, had 691 before.
hamsterdam
30/5/2019
07:08
Hong Kong Stock Exchange 2nd Biotech Summit full stream is now available



You can select the sessions you wish to view

nerdofsteel
29/5/2019
12:16
Wonderfully efficient Company Secretary and NOMAD - RNS within an hour of today's meeting, I look forward to having an even larger number of shares at 8am in the morning!

I continue to Buy

nerdofsteel
Chat Pages: Latest  93  92  91  90  89  88  87  86  85  84  83  82  Older

Your Recent History

Delayed Upgrade Clock